The Gothenburg Breast Screening Trial. (Q47930972)

6 February 2018

title

The Gothenburg Breast Screening Trial. (English)

1 reference

6 February 2018

author

Neil M Walker

7

1 reference

6 February 2018

Jane Warwick

object named as

Jane Warwick

3

0 references

Jan E Mattsson

0 references

author name string

Nils Bjurstam

1

1 reference

6 February 2018

Lena Björneld

2

1 reference

6 February 2018

Evis Sala

4

1 reference

6 February 2018

Stephen W Duffy

5

1 reference

6 February 2018

Lennarth Nyström

6

1 reference

6 February 2018

Erling Cahlin

8

1 reference

6 February 2018

Olof Eriksson

9

1 reference

6 February 2018

Lars-Olof Hafström

10

1 reference

6 February 2018

Halvard Lingaas

11

1 reference

6 February 2018

Jan Mattsson

12

1 reference

6 February 2018

Stellan Persson

13

1 reference

6 February 2018

Carl-Magnus Rudenstam

14

1 reference

6 February 2018

Håkan Salander

15

1 reference

6 February 2018

Johan Säve-Söderbergh

16

1 reference

6 February 2018

Torkel Wahlin

17

1 reference

6 February 2018

language of work or name

English

0 references

publication date

1 May 2003

1 reference

6 February 2018

number of pages

10

1 reference

inferred from page(s)

published in

Cancer

1 reference

6 February 2018

volume

97

1 reference

6 February 2018

page(s)

2387-2396

1 reference

6 February 2018

issue

10

1 reference

6 February 2018

The Edinburgh randomised trial of breast cancer screening: results after 10 years of follow-up

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11361

Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11361

Efficacy of breast cancer screening by age. New results from the Swedish Two-County Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11361

What is the optimum interval between mammographic screening examinations? An analysis based on the latest results of the Swedish two-county breast cancer screening trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11361

Is screening for breast cancer with mammography justifiable?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11361

Long-term effects of mammography screening: updated overview of the Swedish randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11361

Breast cancer screening with mammography: overview of Swedish randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11361

Cochrane review on screening for breast cancer with mammography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11361

Benefits and risks of screening mammography for women in their forties: a statistical appraisal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11361

The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11361

Followup after 11 years--update of mortality results in the Stockholm mammographic screening trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11361

7 January 2021

Randomized study of mammography screening — preliminary report on mortality in the stockholm trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11361

7 January 2021

Benefit of screening mammography in women aged 40-49: a new meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11361

7 January 2021

Breast-cancer screening with mammography in women aged 40-49 years. Swedish Cancer Society and the Swedish National Board of Health and Welfare

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11361

7 January 2021

The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11361

7 January 2021

Screening for breast cancer in women aged under 50: mode of detection, incidence, fatality, and histology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11361

7 January 2021

14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11361

7 January 2021

Reduced breast cancer mortality in women under age 50: updated results from the Malmö Mammographic Screening Program

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11361

7 January 2021

Quantitative Interpretation of Age-Specific Mortality Reductions From the Swedish Breast Cancer-Screening Trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11361

7 January 2021

The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11361

7 January 2021

Identifiers

DOI

10.1002/CNCR.11361

1 reference

6 February 2018

PubMed ID

12733136

1 reference

6 February 2018